CUI JINGRONG JEAN (Chief Scientific Officer) sold 1.8% of their position (11.50K shares) of TURNING POINT THERAPEUTICS, INC. on the open market
Open‑market sale worth $619.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 4 sales
Filed: 5/12/2020ACC: 0001209191-20-028675
DirectorOfficer10% Owner· Chief Scientific Officer
Since Apr 2019
-11.50K
Net shares
Net seller
$619.4K
Total sold
4
Open market trades
0B · 4S
4
Total transactions
11.50K disposed
Non-Derivative Transactions4
Common Stock
Indirect
Shares
−730.00
Price / share
$52.53
Trade value
$38.35K
% of position
0.1%
5/8/2020
637.88K→637.15K
Common Stock
Indirect
Shares
−5.92K
Price / share
$53.49
Trade value
$316.66K
% of position
0.9%
5/8/2020
637.15K→631.23K
Common Stock
Indirect
Shares
−4.75K
Price / share
$54.49
Trade value
$258.83K
% of position
0.8%
5/8/2020
631.23K→626.48K
Common Stock
Indirect
Shares
−100.00
Price / share
$55.16
Trade value
$5.52K
% of position
0.0%
5/8/2020
626.48K→626.38K
Total
Net shares
−11.50K
Net value
-$619.35K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 5/8/2020 | S · Sale | −730.00 | $52.53 | $38.35K | 0.1% | 637.88K | 637.15K |
| Common Stock Indirect | 5/8/2020 | S · Sale | −5.92K | $53.49 | $316.66K | 0.9% | 637.15K | 631.23K |
| Common Stock Indirect | 5/8/2020 | S · Sale | −4.75K | $54.49 | $258.83K | 0.8% | 631.23K | 626.48K |
| Common Stock Indirect | 5/8/2020 | S · Sale | −100.00 | $55.16 | $5.52K | 0.0% | 626.48K | 626.38K |
| Total | −11.50K | -$619.35K | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned300K
Common Stock
DirectShares owned1M
Total
1M direct·300K indirect1.30M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 300K | Indirect |
| Common Stock | 1M | Direct |
| Total | 1.30M | 1M direct·300K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported